References
Julia, V., Macia, L. & Dombrowicz, D. Nat. Rev. Immunol. 15, 308–322 (2015).
Schuijt, T.J. et al. Gut 65, 575–583 (2016).
Yazar, A. et al. Am. J. Gastroenterol. 96, 1511–1516 (2001).
Ekbom, A. et al. Lung 186, 167–172 (2008)
Prescott, H.C. et al. BMJ 353, i2375, 2016.
Gollwitzer, E.S. et al. Nat. Med. 20, 642–647 (2014).
Dickson, R. et al. Nat. Microbiol. http://dx.doi.org/10.1038/nmicrobiol.2016.113 (2016).
Berton, B.S. et al. Respirology 18, 447–454 (2013).
Ader, F. et al. Crit. Care http://dx.doi.org/10.1186/cc10276 (2011).
Mear, J.B. et al. Infect. Immun. 82, 306–315 (2014).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chakradhar, S. A curious connection: Teasing apart the link between gut microbes and lung disease. Nat Med 23, 402–404 (2017). https://doi.org/10.1038/nm0417-402
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0417-402
- Springer Nature America, Inc.
This article is cited by
-
Exploring the immune-inflammatory mechanism of Maxing Shigan Decoction in treating influenza virus A-induced pneumonia based on an integrated strategy of single-cell transcriptomics and systems biology
European Journal of Medical Research (2024)
-
Bidirectional association between pneumonia and intestinal infection: an analysis of the MIMIC-IV database
Internal and Emergency Medicine (2024)
-
Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease
Respiratory Research (2021)
-
Investigating efficacy of “microbiota modulation of the gut-lung Axis” combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial
BMC Cancer (2021)
-
Gut microbiota influence tumor development and Alter interactions with the human immune system
Journal of Experimental & Clinical Cancer Research (2021)